The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms.
D000818:Animals; D001859:Bone Neoplasms / Q000556:secondary; D001862:Bone Resorption; D002478:Cells, Cultured; D003115:Colony-Stimulating Factors / Q000502:physiology; D004195:Disease Models, Animal; D006801:Humans; D006934:Hypercalcemia / Q000209:etiology*; D007984:Leydig Cell Tumor / Q000209:etiology; D008223:Lymphoma / Q000150:complications; D008297:Male; D009101:Multiple Myeloma / Q000150:complications; D009369:Neoplasms / Q000150:complications*; D010010:Osteoclasts / Q000378:metabolism; D010281:Parathyroid Hormone / Q000502:physiology; D010455:Peptides / Q000502:physiology; D011453:Prostaglandins / Q000502:physiology; D051381:Rats; D011956:Receptors, Cell Surface / Q000378:metabolism; D018016:Receptors, Parathyroid Hormone; D013736:Testicular Neoplasms / Q000209:etiology; D015291:Transforming Growth Factors
D003115:Colony-Stimulating Factors; D010281:Parathyroid Hormone; D010455:Peptides; D011453:Prostaglandins; D011956:Receptors, Cell Surface; D018016:Receptors, Parathyroid Hormone; D015291:Transforming Growth Factors